Etac, Baby Boy 1 .

HRN: 22-33-46  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2023
CEFTAZIDIME 1GM (VIAL)
03/02/2023
03/09/2023
IV
100mg
Q8hours
PCAP-C
Waiting Final Action 
03/02/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/02/2023
03/09/2023
IV
15mg
Q8hours
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: